XML 37 R26.htm IDEA: XBRL DOCUMENT
v3.24.3

Stockholders' Equity (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2024
Equity [Abstract] |
Schedule of Outstanding Stock Warrants | Shown below is a summary of the activity of the stock warrants as of and during the nine months ended September 30, 2024:
|  | Public warrants |  | Private warrants |  | PIPE warrants |  | Total
Outstanding, December 31, 2023 |  | 29,268,236 |  |  | 16,400,000 |  |  | 2,052,500 |  |  | 47,720,736 |
Exercise for cash |  | (12,575,664) |  |  | (500,000) |  |  | — |  |  | (13,075,664) |
Noncash exercise in exchange for shares of common stock |  | — |  |  | (15,600,000) |  |  | — |  |  | (15,600,000) |
Outstanding, September 30, 2024 |  | 16,692,572 |  |  | 300,000 |  |  | 2,052,500 |  |  | 19,045,072 |
Schedule of Stock-Based Compensation Expense | Stock-based compensation from stock options and RSUs under the Equity Incentive Plans and from stock options under the Amprius Holdings 2008 Stock Plan that we recorded were included in the following lines in the accompanying condensed consolidated statements of operations during the periods presented (in thousands):
| Three months ended September 30, |  | Nine months ended September 30,
| 2024 |  | 2023 |  | 2024 |  | 2023
Cost of revenue | $ | 223 |  |  | $ | 269 |  |  | $ | 632 |  |  | $ | 682 |
Research and development | 248 |  |  | 27 |  |  | 688 |  |  | 74 |
Selling, general and administrative | 1,249 |  |  | 819 |  |  | 3,588 |  |  | 2,009 |
Total stock-based compensation expense | $ | 1,720 |  |  | $ | 1,115 |  |  | $ | 4,908 |  |  | $ | 2,765 |

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration